Torrent Pharmaceuticals Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For TORNTPHARM, that strike is ₹4,900. Spot at ₹4,857 is near max pain — the expiry magnetic pull is active.
Max Pain Level
The max‑pain strike for Torrent Pharmaceuticals Limited (TORNTPHARM) is ₹4,900. This is the price at which the total premium exposure of option writers would be minimized, so the options market tends to pull the underlying toward this level as expiry approaches.
Spot vs Max Pain Gap
The spot price sits at ₹4,857, about 0.88 % below the max‑pain level. The modest negative gap suggests a slight pull‑back pressure that could encourage the share price to drift upward toward the ₹4,900 zone.
Shift Signal
The max‑pain figure shifted down by ₹50 from the previous day, indicating that option writers have re‑positioned slightly lower. A downward shift often reflects a growing concentration of open interest on the lower‑strike side, reinforcing the magnet effect near the revised max‑pain point.
Expiry Context
As the September 29 expiry draws near (25 days out), the max‑pain mechanism becomes increasingly influential because time decay accelerates and open‑interest‑driven hedging intensifies. Historically, the week preceding expiry sees the underlying gravitate toward the max‑pain strike, though this is a statistical tendency and not a deterministic outcome.
Data Note
The current distance between spot and max‑pain is ₹43, with roughly three and a half weeks remaining until expiry.
Data as of 2026-09-04